Table 6 Relationship between various scores at time zero and future status code (assessed at 3–6 months post-biopsy, status code >1 vs. ≤1) for all UC and IBDU biopsies (N = 141 biopsies).
From: Relating the molecular phenotype of ulcerative colitis to the clinical course
Variable | Mean score at time zero | |||
|---|---|---|---|---|
Biopsies with good future status: status code ≤ 1 | Biopsies with poor future status: status code > 1 | T-test P value | ||
Clinical features | Total Mayo score | 6.11 | 6.81 | 0.35 |
Physician’s global assessment | 1.65 | 1.94 | 0.29 | |
Partial Mayo score | 3.26 | 3.75 | 0.51 | |
Endoscopic Mayo subscore | 1.89 | 2.33 | 0.02 | |
Fecal calprotectin (ug/g) | 758 | 1247 | 0.16 | |
Molecular features | MayoProb1 classifier score | 0.63 | 0.80 | 0.005 |
MayoProb2 classifier score | 0.64 | 0.82 | 0.002 | |
Molecular Calprotectin transcript set score | 2.49 | 3.71 | 0.01 | |